Skip to content

Ultrasonography in Juvenile Idiopathic Arthritis

Changes in Joint-Cartilage as a Measure of Outcome in Juvenile Idiopathic Arthritis - Assessed by Ultrasonography and Biomarkers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01304420
Enrollment
95
Registered
2011-02-25
Start date
2009-10-31
Completion date
2011-11-30
Last updated
2012-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis, Oligoarthritis, Polyarticular Juvenile Rheumatoid Arthritis, Systemic Juvenile Idiopathic Arthritis

Keywords

Juvenile idiopathic arthritis, Ultrasonography, Cartilage, Cartilage biomarkers, Bone biomarkers

Brief summary

The purpose of this study is to analyse the usability of ultrasonography together with biomarkers in the investigation of patients diagnosed with juvenile idiopathic arthritis. The investigators hypothesize that serum and urine markers of cartilage and bone synthesis and degradation, together with ultrasound measurements of joint cartilage thickness, are useful tools in the early evaluation of JIA patients, - as diagnostic, prognostic and monitoring methods.

Interventions

DEVICEUltrasonography

Scanning 5 joints bilaterally with an ultrasound scanner

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Juvenile idiopathic arthritis: Oligoarticular, polyarticular or systemic onset type. * Informed consent from parents * between 5-15 years of age

Exclusion criteria

* Other diagnoses that involves bones or cartilage * Intraarticular steroid injections within 1 month of the trial investigation

Design outcomes

Primary

MeasureTime frameDescription
Joint cartilage thickness1.5 yearsJoint catilage thickness measured by ultrasonography: knee, ankle, wrist, metacarpophalangeal and proximal interphalangeal joints by MRI: one knee by plain radiographs: knee, ankel and wrist

Secondary

MeasureTime frameDescription
Level of different biomarkers in serum and urine1.5 yearsLevel of bone- and cartilage-degradation biomarkers in serum and urine. COMP, CTX-II, RANKL/OPG, PYD/DPD

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026